An economic perspective on urinary tract infection: The "costs of resignation"

Clinical Drug Investigation

Volumn 33, Issue 4, 2013, Pages 255-261

  Ciani, Oriana ^a,b   Grassi, Daniele ^c   Tarricone, Rosanna ^a  

^a BOCCONI UNIVERSITY   (Italy)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c HESPERIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL PRACTICE; CONSULTATION; CRANBERRY JUICE; CYSTITIS; DYSPAREUNIA; ECONOMIC ASPECT; FEMALE; FEMALE SEXUAL DYSFUNCTION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT INFECTION; RETROSPECTIVE STUDY; SEXUAL BEHAVIOR; URINARY TRACT INFECTION; URINE INCONTINENCE; VAGINA PAIN; VISUAL ANALOG SCALE;

COST OF ILLNESS; EPISODE OF CARE; FEMALE; HUMANS; PREVALENCE; QUALITY OF LIFE; URINARY TRACT INFECTIONS;

EID: 84877066754     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.1007/s40261-013-0069-x     Document Type: Article

References (34)

1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003;49(2):53-70.
2. Hannan TJ, Mysorekar IU, Hung CS, et al. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog. 2010;6(8):e1001042.
3. Ikaheimo R, Siitonen A, Heiskanen T, et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis. 1996;22(1):91-9.
4. Foxman B, Gillespie B, Koopman J, et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol. 2000;151(12):1194-205.
5. Sen A. Recurrent cystitis in non-pregnant women. Clin Evid (Online) 2008 Jul 17; 2008. pii: 0801.
6. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103-20.
7. Gupta K, Stamm WE. Pathogenesis and management of recurrent urinary tract infections in women. World J Urol. 1999;17(6):415-20.
8. Nickel JC. Practical management of recurrent urinary tract infections in premenopausal women. Rev Urol. 2005;7(1):11-7.
9. Dason S, Dason JT, Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J. 2011;5(5):316-22.
10. Omigie O, Okoror L, Umolu P, Ikuuh G. Increasing resistance to quinolones: a four-year prospective study of urinary tract infection pathogens. Int J Gen Med. 2009;2:171-5.
11. Grover S, Srivastava A, Lee R, et al. Role of inflammation in bladder function and interstitial cystitis. Ther Adv Urol. 2011;3(1):19-33.
12. Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health. 1990;13(4):227-36.
13. Naber KG, Bergman B, Bishop MC, et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol. 2001;40(5):576-88.
14. Il portale del Servizio Sanitario Regionale dell'Emilia-Romagna. 2011. http://www.saluter.it/documentazione/leggi/regionali/delibere/ aspecialistica-ambulatoriale/dgr.-1065-2006/view?searchterm=None. Accessed 21 Feb 2011.
15. Agenzia Italiana del Farmaco. 2011. http://www.agenziafarmaco.gov.it/it/ content/liste-di-trasparenza-e-rimborsabilita. Accessed 21 Feb 2011.
16. Miller J, Hoffman E. The causes and consequences of overactive bladder. J Womens Health (Larchmt). 2006;15(3):251-60.
17. Nosseir SB, Lind LR, Winkler HA. Recurrent uncomplicated urinary tract infections in women: a review. J Womens Health (Larchmt). 2012;21(3):347-54.
18. Turner D, Little P, Raftery J, et al. Cost effectiveness of management strategies for urinary tract infections: results from randomised controlled trial. BMJ. 2010;340:c346.
19. Nappi RE, Albani F, Vaccaro P, et al. Use of the Italian translation of the Female Sexual Function Index (FSFI) in routine gynecological practice. Gynecol Endocrinol. 2008;24(4):214-9.
20. Ellis AK, Verma S. Quality of life in women with urinary tract infections: is benign disease a misnomer? J Am Board Fam Pract. 2000;13(6):392-7.
21. Abrahamian FM, Krishnadasan A, Mower WR, et al. The association of antimicrobial resistance with cure and quality of life among women with acute uncomplicated cystitis. Infection. 2011;39(6):507-14.
22. Efros M, Bromberg W, Cossu L, et al. Novel concentrated cranberry liquid blend, UTI-STAT with Proantinox, might help prevent recurrent urinary tract infections in women. Urology. 2010;76(4):841-5.
23. Ernst EJ, Ernst ME, Hoehns JD, Bergus GR. Women's quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment. Health Qual Life Outcomes. 2005;3:45.
24. Kaplan RM, Bush JW, Berry CC. Health status: types of validity and the index of well-being. Health Serv Res. 1976;11(4):478-507.
25. Clayson D, Wild D, Doll H, et al. Validation of a patient-administered questionnaire to measure the severity and bothersomeness of lower urinary tract symptoms in uncomplicated urinary tract infection (UTI): the UTI Symptom Assessment questionnaire. BJU Int. 2005;96(3):350-9.
26. Bergman J, Gore JL, Singer JS, et al. Readability of health related quality of life instruments in urology. J Urol. 2010;183(5):1977-81.
27. Tannenbaum C, Corcos J. Outcomes in urinary incontinence: reconciling clinical relevance with scientific rigour. Eur Urol. 2008;53(6):1151-61.
28. Lukacz ES, Lawrence JM, Burchette RJ, et al. The use of Visual Analog Scale in urogynecologic research: a psychometric evaluation. Am J Obstet Gynecol. 2004;191(1):165-70.
29. Abdel-Fattah M, Ramsay I, Barrington JW. A simple visual analogue scale to assess the quality of life in women with urinary incontinence. Eur J Obstet Gynecol Reprod Biol. 2007;133(1):86-9.
30. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27(3 Suppl):S217-32.
31. Brazier JE, Harper R, Munro J, et al. Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology. 1999;38(9):870-7.
32. Allen PF, McMillan AS, Walshaw D, Locker D. A comparison of the validity of generic- and disease-specific measures in the assessment of oral health-related quality of life. Community Dent Oral Epidemiol. 1999;27(5):344-52.
33. Bartoli S, Aguzzi G, Tarricone R. Impact on quality of life of urinary incontinence and overactive bladder: a systematic literature review. Urology. 2010;75(3):491-500.
34. Damiano R, Quarto G, Bava I, et al. Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial. Eur Urol. 2011;59(4):645-51.